Option Care Health (NASDAQ:OPCH) Shares Gap Up to $30.38
Option Care Health (NASDAQ:OPCH) Shares Gap Up to $30.38
Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) gapped up prior to trading on Friday . The stock had previously closed at $30.38, but opened at $31.05. Option Care Health shares last traded at $30.16, with a volume of 561 shares changing hands.
期權護理健康公司(納斯達克：OPCH-GET評級)在週五交易前出現缺口。該股此前收盤報30.38美元，開盤報31.05美元。Option Care Health股票尾盤報30.16美元，成交量為561股。
Analyst Ratings Changes
分析師評級發生變化
Separately, Barrington Research lifted their price objective on Option Care Health from $37.00 to $38.00 and gave the company an "outperform" rating in a report on Friday, October 28th.
另外，Barrington Research在10月28日星期五的一份報告中將Option Care Health的價格目標從37.00美元上調至38.00美元，並給予該公司“跑贏大盤”的評級。
Option Care Health Stock Performance
期權醫療保健股票表現
The company has a 50 day moving average price of $30.25 and a 200-day moving average price of $31.11. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.79. The company has a market cap of $5.47 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 2.83 and a beta of 1.19.
該公司的50日移動均線價格為30.25美元，200日移動均線價格為31.11美元。該公司的流動比率為1.62，速動比率為1.22，債務權益比率為0.79。該公司市值為54.7億美元，市盈率為30.70倍，市盈率為2.83倍，貝塔係數為1.19。
Insider Activity
內幕活動
In related news, Director R Carter Pate sold 1,928 shares of the business's stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $31.97, for a total transaction of $61,638.16. Following the sale, the director now owns 95,530 shares in the company, valued at approximately $3,054,094.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.22% of the company's stock.
在相關新聞中，董事R卡特·佩特在10月3日星期一的一次交易中出售了1,928股該公司的股票。該股以31.97美元的平均價格出售，總成交金額為61638.16美元。交易完成後，董事現在擁有該公司95,530股股份，價值約3,054,094.10美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可在此超鏈接。企業內部人士持有該公司0.22%的股票。
Institutional Investors Weigh In On Option Care Health
機構投資者參與期權醫療保健
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in Option Care Health by 4.9% during the 2nd quarter. FMR LLC now owns 19,738,359 shares of the company's stock worth $548,530,000 after acquiring an additional 918,277 shares during the last quarter. BlackRock Inc. grew its position in Option Care Health by 20.7% during the 3rd quarter. BlackRock Inc. now owns 19,187,400 shares of the company's stock worth $603,829,000 after acquiring an additional 3,290,272 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Option Care Health by 8.1% in the 3rd quarter. Vanguard Group Inc. now owns 15,269,619 shares of the company's stock valued at $480,534,000 after buying an additional 1,147,767 shares during the last quarter. Marshall Wace LLP grew its position in shares of Option Care Health by 27.1% in the 3rd quarter. Marshall Wace LLP now owns 5,000,053 shares of the company's stock valued at $157,355,000 after buying an additional 1,066,480 shares during the last quarter. Finally, State Street Corp grew its position in shares of Option Care Health by 8.2% in the 3rd quarter. State Street Corp now owns 4,841,602 shares of the company's stock valued at $152,365,000 after buying an additional 365,213 shares during the last quarter. Institutional investors own 97.63% of the company's stock.
一些對衝基金和其他機構投資者最近買賣了該公司的股票。第二季度，FMR LLC在Option Care Health的頭寸增加了4.9%。FMR LLC在上個季度額外收購了918,277股後，現在擁有該公司19,738,359股股票，價值548,530,000美元。第三季度，貝萊德公司在Option Care Health的地位增長了20.7%。貝萊德股份有限公司在上個季度增持了3,290,272股後，現在持有19,187,400股該公司股票，價值603,829,000美元。先鋒集團(Vanguard Group Inc.)第三季度將其在Option Care Health的股票頭寸增加了8.1%。先鋒集團目前持有15,269,619股該公司股票，價值480,534,000美元，上一季度又購買了1,147,767股。馬歇爾·華斯有限責任公司在第三季度將其在Option Care Health的股票頭寸增加了27.1%。馬歇爾·華斯有限責任公司在上個季度又購買了1,066,480股後，現在擁有5,000,053股該公司股票，價值157,355,000美元。最後，道富銀行在第三季度將其在Option Care Health的股票頭寸增加了8.2%。道富銀行目前持有該公司4,841,602股股票，價值152,365,000美元，此前該公司在上一季度又購買了365,213股。機構投資者持有該公司97.63%的股份。
About Option Care Health
關於Option Care Health
(Get Rating)
(獲取評級)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Option Care Health，Inc.在美國提供家庭和備用地點輸液服務。該公司提供抗感染治療；治療心力衰竭的家庭輸液服務；治療中風、癌症和胃腸道疾病等多種急慢性疾病的家庭非腸道營養和腸內營養支持服務；治療免疫缺陷的免疫球蛋白輸注療法；以及治療慢性炎症性疾病的治療，包括克羅恩病、斑塊狀牛皮癬、牛皮癬關節炎、類風濕性關節炎、潰瘍性結腸炎和其他慢性炎症性疾病。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
- 免費獲取StockNews.com關於選項護理健康(OPCH)的研究報告
- MarketBeat：回顧一週12/26-12/30
- 科技狗：是時候咬一口這些股票了
- 這筆收購會讓微軟成為熊市買入者嗎？
- 你應該熱身到Generac股票過冬嗎？
- 金塔拉治療公司是一顆隱藏的寶石嗎？
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受《每日健康選擇》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收對Option Care Health和相關公司的最新新聞和分析師評級的簡要每日摘要。